DON'T GAMBLE ON YOUR PATIENT OUTCOMES - Come by RyMed's booth 240 at AVA for your chance to win an iPad mini... fb.me/1oQjra2Xu
DON'T GAMBLE ON YOUR PATIENT OUTCOMES - come by RyMed's booth 240 and play a hand of blackjack for your chance to... fb.me/3cGgE9PZp
Compare your connector to the 10-Point Standard of the InVision-Plus with Neutral Advantage Technology... fb.me/2sDrcvfdd
Learn more about the InVision-Plus CS with Chlorhexidine+Silver Ion Engineering... fb.me/3sjPtEVWg
Learn more about the InVision-Plus CS with Chlorhexidine+Silver Ion Engineering rymedtech.com/products/invis…
Learn more about RyMed Technologies' InVision-Plus CS Needleless IV Connector.... fb.me/3qFRWUNZQ
New study showing PICCs are as risky as CVCs underlines value of best practice in catheter infection control &... fb.me/13mnc3Dex
Study showing PICCs risky as CVCs underlines value of best #infectioncontrol & #vascularaccess. Blog post: ow.ly/ru5or
Comparison of #CLABSI rates when changing to a zero fluid displacement IV connector. #infection journal article. ow.ly/rntXr
European infection prevention conference talks on IV line securement and care bundles for central lines. ow.ly/rntiH
Single-lumen catheters seen as safer and less expensive in hospital #infection study. ow.ly/rcklE
Some #hospitals gain revenue -- and others are hurt -- by #Obamacare system to incentive hospital quality efforts ow.ly/qZvZP
New Guidance Limits Antibiotics for Common Infections in Children. ow.ly/qYlAl
Hospital report cards don't always tell the whole story. ow.ly/qP8wb
IV ROUNDS: Vascular access challenges: Small, fragile veins and tissue-paper skin. Nursing 2013 article (abstract). ow.ly/qOPOV
